AUSTRALIA-WIDE LOW FLAT RATE $9.90

Close Notification

Your cart does not contain any items

$71.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Oxford University Press
19 November 2009
Cervical cancer is the second most common form of cancer found in women and is responsible for more than a quarter of a million deaths worldwide each year.

With approximately 70% of cervical cancers now known to be caused by two oncogenic types of the human papillomavirus (HPV), there is great interest surrounding the approval of the vaccine for clinical use.

Despite this, many questions remain about how the new vaccines should be implemented and how cervical cancer screening will change following vaccination.

This practical pocketbook provides an overview of the role of HPV in the pathophysiology of cervical cancer and its current screening and management, the principles of immune control of HPV infection in cervical cancer, and the challenges of implementing HPV vaccines and future developments. This revised edition includes updated trial data in the chapter on prophylactic HPV vaccination: current status.
Edited by:   , , , ,
Imprint:   Oxford University Press
Country of Publication:   United Kingdom
Edition:   Revised edition
Dimensions:   Height: 180mm,  Width: 100mm,  Spine: 10mm
Weight:   149g
ISBN:   9780199588633
ISBN 10:   0199588635
Series:   Oxford Oncology Library
Pages:   176
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1: Karin Denton: The UK cervical screening programme 2: Julia E. Palmer and John A Tidy: Management of cervical intraepithelial neoplasia (CIN) 3: Sally Roberts and Lawrence S. Young: Role of HPV in cervical carcinogenesis 4: F. Xavier Bosch, Silvia de Sanjosé, and Xavier Castallsagué: HPV and genital cancer: the essential epidemiology 5: Margaret E. Cruickshank: The role of HPV testing in cervical screening 6: Peter L. Stern: Natural immune control of HPV infection 7: Margaret A. Stanley: Prophylactic HPV vaccines: pre-clinical and proof of principle studies 8: Henry C. Kitchener: Prophylactic HPV vaccination: current status 9: Loretta Brabin: Introduction of HPV prophylactic vaccination 10: Rengaswamy Sankaranarayanan and Catherine Sauvaget: HPV vaccination in the developing world 11: Patrick Walker, Adeola Atilade, and Henry C. Kitchener: Screening post vaccination 12: Richard BS Roden: Second-generation HPV prophylactic vaccines 13: Sjoerd H. van der Burg: Therapeutic HPV vaccines 14: Peter L. Stern and Henry C. Kitchener: Conclusion

Peter L. Stern is Professor of Immunology, Patterson Institute of Cancer Research, Christie Hospital NHS Trust, University of Manchester, Manchester, UK Henry C. Kitchener is Professor of Gynacological Oncology at St. Mary's Hospital, University of Manchester, manchester, UK

See Also